Think Bioscience
Develops small molecule drugs for historically challenging drug targets
$55MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops small molecule drugs for historically challenging drug targets
Develops cancer therapies that activate the immune system to detect and destroy cancer cells in t...
Pitching YK Bioventures? Send the deck from a free RoundOS data room and see which pages they read.